Pharmacokinetics of topical ocular drug delivery: Potential uses for the treatment of diseases of the posterior segment and beyond

Current Drug Metabolism

Volumn 4, Issue 3, 2003, Pages 213-222

  Koevary, Steven B ^a  

^a NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIALLERGIC AGENT; ANTIGLAUCOMA AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPENTOLATE; DICLOFENAC; DORZOLAMIDE; IMIRESTAT; INSULIN; KETOROLAC; LATANOPROST; MEPYRAMINE; METIPRANOLOL; MYDRIATIC AGENT; NEOMYCIN; PENICILLIN G; PEPTIDE; PHENYLEPHRINE; PROSTAGLANDIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMOLOL; TIMOLOL MALEATE; TROPICAMIDE; UNINDEXED DRUG; VASCULOTROPIN;

ANTERIOR EYE SEGMENT; BRADYCARDIA; CENTRAL NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; CONJUNCTIVA; CORNEA; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; EYE DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; INTRAOCULAR PRESSURE ABNORMALITY; MOLECULAR WEIGHT; OPTIC NERVE; POSTERIOR EYE CHAMBER; RESPIRATORY ARREST; RETINA NEOVASCULARIZATION; REVIEW; SCLERA; SUBRETINAL NEOVASCULARIZATION; TACHYCARDIA;

ABSORPTION; ANIMALS; BRAIN; DIFFUSION; DRUG THERAPY; EYE; EYE DISEASES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; OPHTHALMIC SOLUTIONS; PHARMACEUTICAL PREPARATIONS;

EID: 0038136601     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200033489488     Document Type: Review

References (166)

1. Wood, C.A. (1917) The American Encyclopedia and Dictionary of Ophthalmology, XI. Cleveland Press, Chicago, pp. 8830-8851.
2. Williams, P.B., Crouch, E.R., Sheooard, J.D., Lattanzio, F.A., Parker, T.A. and Mitrev, P.V. (2000) J. Clin. Pharmacol., 40(9), 990-1006.
3. Bullard, J.W. (1904) Trans. AM Acad. Ophthalmol. Otolaryngol., 12, 1943-1948.
4. Gillies, W.E. and Brooks, A.M. (1998) Aust. N.Z. J. Ophthalmol., 26(3), 215-218.
5. Stamper, R.L., Wigginton, S.A. and Higginbotham, E.J. (2002) Surv. Ophthalmol., 47(1), 63-73.
6. Willis, A. M., Diehl K.A. and Robbin, T.E. (2002) Vet. Ophthalmol., 5(1), 9-17.
7. Whitson, J.T. (2002) Expert Opin. Pharmacother., 3 (7), 965-977.
8. Eisenberg, D.L. Toris, C.B. and Camras, C.B. (2002) Surv. Ophthalmol., 47 Suppl. 1, S105-115.
9. Black, R.L., Oglesby, R.B. and von Sallman, L. (1960) JAMA, 174, 166-171.
10. Covell, L.L. (1958) Am. J. Ophthalmol., 45, 108.
11. Becker, B. and Mills, D.W. (1963) JAMA, 184, 170-172.
12. McGhee, C.N. (1992) Br. J. Ophthalmol., 76(11), 681-684.
13. Salminen, L. (1990) J. Ocul. Phamacol., 6(3), 243-249.
14. Lama, P.J. (2002) Am. J. Ophthalmol., 134(5), 749-760.
15. Sica, D.A. (2001) J. Clin. Hypertens., 3(3), 175-178.
16. Gordon, D.M. and McLean, J.M. (1950) J. Am. Med. Assoc., 142, L1271-1276.
17. Weiss, D.I. and Shaffer, R.N. (1962) Arch. Ophthalmol., 68, 727-729.
18. de Smet, M.D. and Nussenblatt, R.R. (1993) Int. Ophthalmol. Clin., 33(4), 31-45.
19. Pucci, N, Novembre, E., Cianferoni. A., Lombardi, E., Bernardini, R., Caputo, R., Campa, L., Vierucci, A. (2002) Ann. Allergy Asthma Immunol., 89(3), 298-303.
20. Takeno, S. T. (2000) Expert Opin. Investig. Drugs, 9(9), 1993-2005.
21. Lee, T.W. and Robinson, J.R. (2001) J. Ocular Pharmacol. Ther., 17(6), 565-572.
22. Yanagi, Y., Tamaki, Y., Obata, R., Muranaka, K., Homma N., Matsuoka, H. and Mano, H. (2002) Invest. Ophthalmol. Vis. Sci.. 43(11), 3495-3499.
23. Zamir, E., Rcad, R.W., Smith, R.E., Wang, R.C. and Rao, N.A. (2002) Ophthalmology. 109(4), 798-805.
24. Tanner, V., Kanski, J.J. and. Frith, J.A. (1998) Eye, 12 679-685.
25. Schlaegel, T.F. Jr and Weber, J.C. (1977) Surv. Ophthalmol., 22, 125-130.
26. Kumar, C.M. and Dodds, C. (2001) Br. J. Anaesth., 87(4):631-633.
27. Munoz-Negrete, R. G. and Gutierrez-Ortiz, F.J. C. (2001) J. Cataract Refract. Surg., 27(8), 1214-1220.
28. Sasaki, H., Kashiwagi, S., Mukai, T., Nishida, K., Nakamura, J., Nakashima, M., Ichikawa, M. (1999) Biol. Pharm. Bull., 22(9), 956-960.
29. Bochot, A., Couvreur, P. and Fattal, E. (2000) Prog. Retin. Eye Res., 19(2), 131-147.
30. Jonas, J.B., Kreissig, I. and Degenring, R.F. (2002) Graefes Arch. Clin. Exp. Ophthalmol., 240(9), 782-3.
31. Martidis, A., Duker, J.S., Greenberg, P.B., Rogers, A.H., Puliafito, C.A., Reichel, E. and Baumal, C. (2002) Ophthalmology., 109(5), 920-927.
32. Haider, S.A., Hassett, P. and Bron, A.J. (2001) Retina, 21(3), 210-213.
33. Jonas, J.B., Hayler, J.K., Sofker, A. and Panda-Jonas, S. (2001) Am. J. Ophthalmol., 131(4), 468-471.
34. Harbour, J.W., Worley, L., Ma, D. and Cohen, M. (2002) Arch. Ophthalmol. 120(10), 1341-1346.
35. Wygnanski-Jaffe, T., Belkin, M., Rosner, M.and Yoseph, G. (2001) Ophthalmic Surg. Lasers, 32(2), 140-144.
36. Pinilla, I., Larrosa, J.M., Polo, V. and Honrubia, F.M. (1998) Ophthalmologica, 212(5), 306-309.
37. Mietz, H., Diestelhorst, M., Rump, A.F., Theisohn, M., Klaus W. and Krieglstein, G.K. (1998) Ophthalmologica, 212(1), 37-42.
38. Schepens, C.L. and Acosta, F. (1991) Surv. Ophthalmol., 35(6), 447-453.
39. Yasukawa, T., Kimura, H., Kunou, N., Miyamoto, H., Honda, Y., Ogura, Y. and Ikada, Y. (2000) Graefes Arch. Clin. Exp. Ophthalmol. 238(2), 186-190.
40. Kunou, N., Ogura, Y., Yasukawa, T., Kimura, H., Miyamoto, H., Honda, Y. and Ikada, Y. (2000) J. Control. Release, 68(2), 263-271.
41. Kunou, N., Ogura, Y., Honda, Y., Hyon, S.H. and Ikada, Y. (2000) J. Biomed. Mater. Res., 51(4), 635-641.
42. Rolando, M. and Zierhut, M. (2001) Surv. Ophthalmol., 45(Suppl. 2). S203-210.
43. Jordan, A. and Baum, J. (1980) Ophthalmology, 87(9), 920-930.
44. Buck, R.C. (1985) Invest. Ophthalmol. Vis. Sci., 26(9), 1296-1299.
45. Buck, R.C. (1979) Invest. Ophthalmol. Vis. Sci., 18(8), 767-784.
46. Dilly, P.N. (1994) Adv. Exp. Med. Biol., 350, 239-247.
47. Holly, F.J. (1973) Exp. Eye Res., 15(5), 515-525.
48. Prydal, J.I., Artal P., Woon H. and Campbell, F. W. (1992) Invest. Ophthalmol. Vis. Sci., 33(6), 2006-2011.
49. McCulley, J.P. and Shine, W.E. (2001) Biosci. Rep., 21(4). 407-418.
50. Nguyen, D.H., Beuerman, R.W., Meneray, M.A. and Maitchouk, D. (1998) Adv. Exp. Med. Biol., 438, 55-62.
51. Sullivan, D.A., Krenzer, K.L. Sullivan B.D. (1999) Invest. Ophthalmol. Vis. Sci., 40(6), 1261-1265.
52. Fiscella, R.G. and Burstein, N.L. (2001) Clinical Ocular Pharmacology, Bartlett and Jaanus, 4th edition, 19.
53. Mishima, S. and Maurice, D.M. (1961) Exp. Eye Res., 1, 39.
54. Rolando, M., Refojo, M.F. and Kenyon, K.R. (1985) Ophthalmologica, 190(3), 147-149.
55. Sack, R.A., Nunes, I., Beaton, A.and Morris, C. (2001) Biosci. Rep., 21(4), 463-480.
56. Rolando, M. and Refojo, M.F. (1983) Exp. Eye Res., (1983) 36(1), 25-33.
57. Dursun, D., Monroy, D. and Knighton, R. (2000) Ophthalmology, 107(9), 1754-1760.
58. Mishima, S., Gasset, A., Klyce, S.D. and Baum, J.L. (1966) Invest. Ophthalmol., 5(3), 264-276.
59. Stjernschantz, J. and Astin, M. (1993) Anatomy and Physiology of the Eye. Physiological Aspects of Ocular Drug Therapy. In: Biopharmaceutics of Ocular Drug Delivery, Edman, P. ed., 9.
60. Patton, T.F. and Francoeur, M. (1978) Am. J. Ophthalmol., 85, 225-229.
61. Frishman, W.H., Kowalski, M., Nagnur, S., Warshafsky, S. and Sica, D. (2001) Heart Dis., 3(6), 386-397.
62. Frangie, J.P. (1995) Clin. Pharmacokinet., 29(2), 130-138.
63. Ludwig, A., van Haeringen, N.J., Bodelier, V.M. and Van Ooteghem, M. (1992) Int. Ophthalmol., 16(1), 23-26.
64. Patton, T.F. and Robinson, J.R. (1975) J. Pharm. Sci., 64, 1312-1315.
65. MacKeen, D.L. (1980) Int. Ophthalmol. Clin., 20(3), 79-92.
66. Cox, W. V., Kupferman, A. and Leibowitz, H.M. (1972) Arch. Ophthalmol., 88(5), 549-552.
67. Davies, N. M. (2000) Clin, Exp. Pharmacol. Physiol., 7, 558-562.
68. Loftssona, T. and Järvinen, T. (1999) Adv. Drug Delivery Revs. 36, 59-79.
69. Bary, A. R., Tucker, I. G. and Davies, N. M. (2000) Eur. J. Pharm. Biopharm., 50, 237-244.
70. Saettone, M.F. (2002) Business Briefing: Pharmatech, 3.
71. Quigley, H.A., Pollack, I.P. and Harbin, TS. (1975) Arch. Ophthalmol., 93, 771-775.
72. O'Brien, T.P., Sawusch, M.R., Dick, J.D., Hamburg, T.R. and Gottsch, J.D. (1988) J. Cataract Refract. Surg., 14, 505-507.
73. Lee, Y.C., Millard, J., Negvesky, G.J., Butrus, S.I. and Yalkowsky, S.H. (1999) Int. J. Pharm., 182(1), 121-126.
74. Bawa, R. (1993) Ocular Inserts In: Mitra, AK (ed), Ophthalmic Drug Delivery Systems. Marcel Dekker Inc.: New York, US, 223-260.
75. Diestelhorst, M., Grunthal, S. and Suverkrup, R. (1999) Graefes Arch. Clin. Exp. Ophthalmol., 237, 394-398.
76. Wang, W., Sasaki, H., Chien, D.S. and Lee, V.H.L. (1991) Curr. Eye Res., 10(6), 571-579.
77. Schoenwald, R.D. (1993) Pharmacokinetics in ocular drug delivery. In: Biopharmaceutics of Ocular Drug Delivery, Edman, P. ed., page 176.
78. Acheampong, A.A., Shackleton, M., Tang-Liu, D.D., Ding, S., Stern, M.E. and Decker, R. (1999) Curr. Eye Res., 18(2), 91-103.
79. Schoenwald, R.D. and Huang, H.S. (1983) J. Pharm. Sci., 72, 1266-1272.
80. Schoenwald, R.D. and Ward, R.L. (1978) J. Pharm. Sci., 67, 786-788.
81. Bundgaard, H., Falch, E., Larsen, C., Mosher, G.L., Mikkelson, T.J. (1986) J. Pharm. Sci., 75(8), 775-783.
82. Lee, V.H., Chang, S.C., Oshiro, C.M. and Smith, R.E. (1985) Curr. Eye Res., 4(11), 1117-1125.
83. Lien, E.J., Alhaider, A.A. and Lee, V.H. (1982) J. Parenter. Sci. Technol., 36(2), 86-93.
84. Nakamura, M., Shirasawa, E. and Hikida M. (1993) Ophthalmic Res., 25(1), 46-51.
85. Jarvinen, T., Poikolainen, M., Suhonen, P., Vepsalainen, J., Alaranta, S. and Urtti, A. (1995) J. Pharm. Sci., 84(5), 656-660.
86. Nakamura, M., Shirasawa, E. and Hikida, M. (1993) Ophthalmic Res., 25(1), 46-51.
87. Sasaki, H., Yamamura, K., Mukai, T., Nishida, K., Nakamura, J., Nakashima, M. and Ichikawa M. (1999) Crit. Rev. Ther. Drug Carrier Syst., 16(1), 85-146.
88. Urtti, A. (1994) J. Ocul. Pharmacol., 10(1), 349-357.
89. Wei, C.P. and Anderson, J.A. (1978) Invest. Ophthalmol. Vis. Sci., 17(4), 315-321.
90. Chien D.S., Tang-Liu, D.D. and Woodward, D.F. (1997) J. Pharma. Sci., 86(10), 1180-1186.
91. Madhu, C., Rix, P., Nguyen, T., Chien, D.S., Woodward, D.F. and Tang-Liu, D.D. (1998) J. Ocul. Pharmacol. Ther., 14(5), 389-399.
92. Sunkara, G., Deruiter, J., Clark, C.R. and Kompella, U.B. (2000) J. Pharm. Pharmacol., 52(9), 1113-1122.
93. Suhonen, P., Jarvinen, T., Koivisto, S. and Urtti, A. (1998) Eur. J. Pharm. Sci., 6(3), 169-176.
94. Ke, T.L., Graff, G., Spellman, J.M. and Yanni, J.M. (2000) Inflammation, 24(4), 371-384.
95. Takahashi, K., Saishin, Y., Saishin, Y., Mori, K. ando, A., Yamamoto, S., Oshima, Y., Nambu, II., Melia, M.B., Bingaman, D.P. and Campochiaro, P.A. (2003) Invest. Ophthalmol. Vis. Sci., 44(1), 409-415.
96. Huang, A.J., Tseng, S.C. and Kenyon, K.R. (1989) Invest. Ophthalmol. Vis. Sci., 30(4), 684-689.
97. Hamalainen, K.M., Kananen, K., Auriola, S., Kontturi, K. and Urtti, A. (1997) Invest. Ophthalmol. Vis. Sci., 38(3), 627-634.
98. Ahmed, I. and Patton, T.F. (1985) Invest. Ophthalmol. Vis. Sci., 26(4), 584-587.
99. Schoenwald, R., Deshpande, G.S., Rethwisch, D.G. and Barfknecht, C.F. (1997) J. Ocular Pharmacol., 13, 41-59.
100. Edelhauser, H.F. and Maren, T.H. (1988) Arch. Ophthalmol., 106(8), 1110-1115.
101. Chien, D.S., Homsy, J.J., Gluchowski, C. and Tang-Liu, D.D. (1990) Curr. Eye Res., 9(11), 1051-1059.
102. Pech, B., Chetoni, P., Saettone, M.F., DuVal, O. and Benoit, J.P. (1993) J. Ocular Pharm., 9(2), 141-150.
103. Geroski, D.H. and Edelhauser, H.F. (2001) Adv. Drug Deliv. Rev., 52, 37-48.
104. Behar-Cohen, F.F., El Aouni, A., Gautier, S., David, G., Davis, J.. Chapon, P. and Parel, J.M. (2002) Exp. Eye Res., 74(1), 51-59.
105. Olsen, T.W., Edelhauser, H.F., Lim, J.I. and Geroski, D.H. (1995) Invest. Ophthalmol. Vis. Sci., 36(9), 1893-1903.
106. Rudnick, D.E., Noonan, J.S., Geroski, D.H., Prausnitz, M.R. and Edelhauser, H.F. (1999) Invest. Ophthalmol. Vis. Sci., 40(12), 3054-3058.
107. Simpson, A.E., Gilbert, J.A., Rudnick, D.E,. Geroski, D.H, Aaberg, T.M Jr. and Edelhauser, H.F. (2002) Arch. Ophthalmol., 120(8), 1069-1074.
108. Carrasquillo, K.G., Ricker, J.A., Rigas, I.K., Miller, J.W., Gragoudas, E.S. and Adamis, A.P. (2003) Invest. Ophthalmol. Vis. Sci., 44(1), 290-299.
109. Ambati, J., Canakis, C.S., Miller, J.W., Gragoudas, E.S., Edwards, A., Weissgold, D.J., Kim, I., Delori, F.C. and Adamis, A.P. (2000) Invest. Ophthalmol. Vis. Sci., 41(2), 1181-1185.
110. Arend, O., Harris. A., Arend, S., Remky, A., Martin, B.J. (1998) Acta Ophthalmol. Scand., 76(1), 43-49.
111. Grunwald, J.E. (1986) Invest. Ophthalmol. Vis. Sci., 27(12), 1713-1719.
112. Grunwald, J.E. (1990) Invest. Ophthalmol. Vis. Sci., 31(3), 521-526.
113. Haefliger, I.O., Lietz, A., Griesser, S.M., Ulrich, A., Schotzau, A., Hendrickson, P. (1999) Flammer J. Surv. Ophthalmol., 43 Suppl. 1, S59-65.
114. Richard, G., Weber, J. (1987) Klin. Monatsbl. Augenheilkd., 190(1), 34-39. German.
115. Schmetterer, L., Strenn, K., Findl, O., Breiteneder, H., Graselli, U., Agneter, E., Eichler, H.G., Wolzt, M. (1997) Clin. Pharmacol. Ther., 61(5), 583-595.
116. Tamaki, Y., Araie, M., Tomita, K., Nagahara, M., Tomidokoro, A. (1997) Curr. Eye Res. 16(11), 1102-1110.
117. Yoshida, A., Feke, G.T., Ogasawara, H., Goger, D.G., Murray, D.L., McMeel, J.W. (1991) Ophthalmic Res., 23(3), 162-170.
118. Harris, A., Arend, O., Chung, H.S., Kagemann, L., Cantor, L., Martin, B. (2000) Ophthalmology, 107(3), 430-434.
119. Harris, A., Spaeth, G.L., Sergott, R.C., Katz, L.J., Cantor, L.B., Martin, B.J. (1995) Am. J. Ophthalmol., 120(2), 168-175.
120. Harris, A., Arend, O., Arend, S., Martin, B. (1996) Acta Ophthalmol. Scand., 74(6), 569-572.
121. Harris, A., Arend, O., Kagemann, L., Garrett, M., Chung, H.S., Martin, B. J. (1999) Ocul. Pharmacol. Ther., 15(3). 189-197.
122. Martinez, A., Gonzalez, F., Capeans, C., Perez, R., Sanchez-Salorio, M. (1999) Invest. Ophthalmol. Vis. Sci., 40(6), 1270-1275.
123. Grunwald, J.F., Mathur, S., DuPont, J. (1997) Acta Ophthalmol. Scand., 75(3), 236-238.
124. Pillunat, L.E., Bohm, A.G., Koller, A.U., Schmidt, K.G., Klemm, M., Richard, G. (1999) Graefes Arch. Clin. Exp. Ophthalmol., 237(6), 495-500.
125. Seong, G.J., Lee, H.K., Hong, Y.J. (1999) Ophthalmologica, 213(6), 355-359.
126. Maurice, D.M. (2002) Surv. Ophthalmol., 47(Suppl. 1), S41-S52.
127. Salazar-Bookaman, M.M., Wainer, I. and Patil, P.N. (1994) J. Ocular Pharmacol., 10(1), 217-239.
128. Eves, P., Smith-Thomas, L., Hedley, S., Wagner, M., Balafa, C. and Mac Neil, S. (1999) Pigment Cell Res., 12(1), 22-35.
129. Leblanc, B., Jezequel, S., Davies, T., Hanton, G. and Taradach C. (1998) Regul. Toxicol. Pharmacol., 28(2), 124-132.
130. Kessler, C., Bleckmann, H, and Kleintges, G. (1991) Graefes Arch. Clin. Exp. Ophthalmol., 229(5), 487-491.
131. Joshi, A., Maurice, D. and Paugh, J.R. (1996) Invest. Ophthalmol. Vis. Sci., 37(6), 1008-1016.
132. Koyano, S., Araie, M. and Eguchi, S. (1993) Invest. Ophthalmol. Vis. Sci., 34(3), 531-538.
133. Macdonald, E.A. and Maurice, D.M. (1991) Exp. Eye Res., 53(4), 427-430.
134. Koevary, S.B., Nussey, J. and Lake, S. (2001) Invest. Ophthalmol. Vis. Sci., 43(3), 797-804.
135. Patsiopoulos, G., Lam, V., Lake, S. and Koevary, S.B. (2003) Optometry, in Press.
136. Zimmerman, T.J. and Kaufman, H.E. (1977) Arch. Ophthalmol., 95(4), 605-607.
137. Piltz, J., Gross, R., Shin, D.H., Beiser, J.A., Dorr, D.A., Kass, M.A., Gordon, M.O. and the Ocular Hypertension Study Group; (2000) Am. J. Ophthalmol., 130(4), 441-453.
138. Drance, S.M. (1980) Surv. Ophthalmol., 25(3), 203-205.
139. Kwitko, G.M., Shin, D.H., Ahn, B.H. and Hong, Y.J. (1987) Am. J. Ophthalmol., 104(6), 591-594.
140. The glaucoma laser trial: GLT Research Group. (1991) Ophthalmic Surg., 22(6), 324-329.
141. Martin, X.D. and Rabineau, P.A. (1988) Ophthalmology, 95, 1620-1623.
142. Vareilles, P., Silverstone, D., Plazonnet, B., Le Douarec, J.C., Sears, M.L. and Stone, C.A. (1977) Invest. Ophthalmol. Vis. Sci., 16, 987-996.
143. Bartels, S.P., Roth, H.O., Jumblatt, M.M. and Neufeld, A.H. (1980) Invest. Ophthalmol. Vis. Sci., 19, 1189-1197.
144. Colasanti, B.K. and Trotter, R.R. (1981) Invest. Ophthalmol. Vis. Sci., 20 69-76.
145. Fraunfelder, F.T. (1986) Arch. Intern. Med., 146 1073-1074.
146. Shiuey, Y., Eisenberg, M.J. (1996) Clin. Cardiol., 19, 5-8.
147. Saari, K.M., Ali-Melkkila, T., Vuori, M.L., Kaila, T. and Iisalo, E. (1993) Acta. Ophthalmol., 71, 671-676.
148. Radius, R.L., Diamond, G.R., Pollack, I.P. and Langham, M.E. (1978) Arch. Ophthalmol., 96, 1003-1008.
149. Gibbens, M.V. (1988) Br. J. Ophthalmol., 72, 746-749.
150. Koevary, S.B. Lam, V. and Patsiopoulos, G. (2002) Invest. Ophthalmol. Vis. Sci., May 2002, ARVO abstract #2325.
151. Koevary, S., Patsiopoulos, G., Lam, V. and Lake, S. (2003) J. Ocul. Pharmacol. Ther., Submitted.
152. Shwartz, M.W., Sipols, A., Kahn, S.E., Latteman, D.F., Taborsky, G.J. Jr., Bergman, R.N., Woods, S.C. and Porte, D. Jr. (1990) Am. J. Physiol., 259(3 Part 1), E378-383.
153. Baura, G.D., Foster, D.M., Porte, D. Jr., Kahn, S.E., Bergman, R.N., Cobelli, C. and Schwartz, M.W. (1993) J. Clin. Invest., 92, 1824-1830.
154. Banks, W.A., Jaspan, J.B. and Kastin, A.J. (1997) Peptides, 18 1257-1262.
155. Steffens, A.B., Scheurink, A.J., Porte, D. Jr. and Woods, S.C. (1988) Am. J. Physiol., 255, R200-R204.
156. Pardridge, W.M. (2002) Nat. Rev. Drug Discov., 1(2), 131-139.
157. Fisher, R. S. and Ho, J. (2002) CNS Drugs, 16(9), 579-593.
158. Rainov, N.G. and Kramm, C.M. (2001) Curr. Gene Ther., 1(4), 367-383.
159. Regina, A., Demcule, M., Laplante, A., Jodoin, J., Dagenais, C., Berthelet, F., Moghrabi, A. and Beliveau, R. (2001) Cancer Metastasis Rev., 20(1-2), 13-25.
160. Siegal, T. and Zylber-Katz, E. (2002) Clin. Pharmacokinet., 41(3), 171-186.
161. Kraemer, D.F., Fortin, D. and Neuwelt, E.A. (2002) Curr. Neurol. Neurosci. Rep., 2(3), 216-224.
162. Deleu, D., Northway, M.G. and Hanssens, Y. (2002) Clin. Pharmacokinet., 41(4), 261-309.
163. Lee, H.J., Engelhardt, B., Lesley, J., Bickel, U. and Pardridge, W.M. (2000) J. Pharmacol. Exp. Ther., 292(3), 1048-1052.
164. Groothuis, D.R. (2000) Neuro-oncol., 2(1), 45-59.
165. Broaddus, W.C., Gillies, G.T. and Kucharczyk, J. (2001) Neuroimaging Clin. N. Am., 11(4), 727-735.
166. Rait, J.L. (1999) Aust. N. Z. J. Ophthalmol., 27(1), 57-64.